SC 13D Filing

Company

Finch Therapeutics Group, Inc.

Filed

March 29, 2021

Accession Number

0001137439-21-000195

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →